Invention Grant
- Patent Title: Oral pharmaceutical products and methods of use combining testosterone esters with hypolipidemic agents
-
Application No.: US15107492Application Date: 2014-12-24
-
Publication No.: US10245273B2Publication Date: 2019-04-02
- Inventor: Wael Salameh , Panayiotis Constantinides
- Applicant: Clarus Therapeutics, Inc.
- Applicant Address: US IL Northbrook
- Assignee: Clarus Therapeutics, Inc.
- Current Assignee: Clarus Therapeutics, Inc.
- Current Assignee Address: US IL Northbrook
- Agent Dennis A. Bennett; Brock D. Levin
- International Application: PCT/US2014/072332 WO 20141224
- International Announcement: WO2015/100406 WO 20150702
- Main IPC: A61K31/568
- IPC: A61K31/568 ; A61K31/192 ; A61K31/195 ; A61K31/216 ; A61K9/107 ; A61K9/20 ; A61K9/48 ; A61K45/06 ; A61K9/14
Abstract:
Pharmaceutical products comprising a hypolipidemic agent and a testosterone ester such as testosterone undecanoate are provided. Methods of safely treating a testosterone deficiency or its symptoms with the inventive pharmaceutical products are also provided.
Public/Granted literature
- US20160317553A1 ORAL PHARMACEUTICAL PRODUCTS AND METHODS OF USE COMBINING TESTOSTERONE ESTERS WITH HYPOLIPIDEMIC AGENTS Public/Granted day:2016-11-03
Information query
